US Drug Test Centers Blog
Does a Standard Drug Test Catch Fentanyl?
Fentanyl is the deadliest drug in America. So most people assume a workplace drug test checks for it. Most of the time, it does not. Here is what you need to know.
Why Most Tests Miss It
Fentanyl is a synthetic opioid. It is made in a lab, not from the poppy plant like heroin or morphine.
A standard "opiates" screen looks for drugs like morphine and codeine. Fentanyl is built differently, so it does not trigger that screen. Unless a test specifically includes fentanyl, it will not find it.
The common 5-panel test used for years covers marijuana, cocaine, amphetamines, opiates, and PCP. Fentanyl is not on that list.
What Has Changed at the Federal Level
The rules for federal testing are starting to catch up.
-
July 7, 2025: The U.S. Department of Health and Human Services (HHS) added fentanyl and its main byproduct, norfentanyl, to the federal workplace drug testing panel. That covers federal agency employees.
-
September 2, 2025: The Department of Transportation (DOT) proposed adding fentanyl and norfentanyl to its testing panel as well.
Is Fentanyl Part of DOT Testing Yet?
Not yet. As of fall 2026, DOT has not published a final rule, and there is no effective date. Until that happens, DOT drug tests stay the same.
That also means DOT employers cannot add fentanyl to their DOT test on their own. A DOT test has to follow the DOT panel exactly. When the final rule comes out, it will apply to every type of DOT test: pre-employment, random, post-accident, reasonable suspicion, return-to-duty, and follow-up.
Non-DOT Employers Can Test for Fentanyl Today
If your company is not DOT-regulated, you do not have to wait. You can add fentanyl to your company's drug testing panel now, as long as your policy says so and your state allows it.
If you have both DOT and non-DOT team members, keep the two programs separate. Fentanyl testing for non-DOT workers should be its own test, not mixed into a DOT test.
Is Testing Actually Making a Difference?
The numbers suggest it is. The 2026 Quest Diagnostics Drug Testing Index found that fentanyl positive rates in the U.S. workforce dropped by almost half in one year, from 0.55% in 2024 to 0.28% in 2025. Quest said the drop may reflect employers adding fentanyl testing, education, and other steps to discourage use.
Earlier Quest data also found that fentanyl was much more likely to turn up in random tests than in pre-employment tests. That makes sense. People often know a pre-employment test is coming. Random tests do not give that warning.
Why Employers Should Care
Fentanyl is so strong that a tiny amount can cause an overdose. In a workplace, the risks include:
-
Safety. An impaired worker on a forklift, a roof, or a road can hurt themselves or others.
-
Overdose at work. Some employers now keep naloxone (Narcan) on site and train team members to use it.
-
Mixed drug use. Fentanyl often shows up alongside other drugs, sometimes without the user knowing it was there.
What Employers Should Do Now
-
Check your panel. Ask your provider exactly what your non-DOT test includes. Do not assume.
-
Consider adding fentanyl to non-DOT testing, especially for random and safety-sensitive roles.
-
Update your written policy so it names fentanyl if you add it.
-
Watch for the DOT final rule. When it comes out, your DOT program will change on DOT's timeline.
How US Drug Test Centers can help
US Drug Test Centers offers fentanyl testing for non-DOT programs and for individuals. We can review your current panel, help you add fentanyl the right way, and keep your DOT and non-DOT testing separate and compliant. When the DOT rule is finalized, we will help you make the change.
Call 866-566-0261 or visit www.usdrugtestcenters.com.
